Chemotherapy of brain tumors.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001375:Azaguanine / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy*; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D004357:Drug Synergism; D005472:Fluorouracil / Q000627:therapeutic use; D005909:Glioblastoma / Q000188:drug therapy; D005910:Glioma / Q000188:drug therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008527:Medulloblastoma / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D008926:Plicamycin / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D013308:Streptonigrin / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D009607:Nitrosourea Compounds; D001761:Bleomycin; D013308:Streptonigrin; D011344:Procarbazine; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D008926:Plicamycin; D001375:Azaguanine; D005472:Fluorouracil; D006918:Hydroxyurea; D008727:Methotrexate